Home
About
Overview
Sharing Data
ORCID
Help
History (56)
Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
Methoxamine
Message to the FDA on ESAs: REMS is not enough, more studies are needed.
Publisher Correction: Shared proteomic effects of cerebral atherosclerosis and Alzheimer's disease on the human brain.
Anxiety rating scales in Parkinson's disease: critique and recommendations.
See All 56 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Anxiety rating scales in Parkinson's disease: critique and recommendations.
Anxiety rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2008 Oct 30; 23(14):2015-25.
View in:
PubMed
subject areas
Anxiety Disorders
Evaluation Studies as Topic
Humans
Parkinson Disease
Psychiatric Status Rating Scales
Psychometrics
Reproducibility of Results
authors with profiles
Christopher Goetz